101 related articles for article (PubMed ID: 1976126)
1. Immunoreactive gastrin-releasing peptide in medullary thyroid carcinoma.
Modigliani E; Casanova S; Chayvialle JA; Bernard C; Franc B; Cohen R; Calmettes C
J Clin Endocrinol Metab; 1990 Oct; 71(4):831-5. PubMed ID: 1976126
[TBL] [Abstract][Full Text] [Related]
2. The intratumoral immunoassayable somatostatin concentration is frequently elevated in medullary thyroid carcinoma. Results in 34 cases.
Modigliani E; Alamowitch C; Cohen R; Calmettes C; Guliana JM; Franc B; Bernard C; Chayvialle JA
Cancer; 1990 Jan; 65(2):224-8. PubMed ID: 1967221
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin, calcitonin gene-related peptide, and gastrin-releasing peptide in familial thyroid medullary carcinoma.
Månsson B; Ahrén B; Nobin A; Böttcher G; Sundler F
Surgery; 1990 Feb; 107(2):182-6. PubMed ID: 2300897
[TBL] [Abstract][Full Text] [Related]
4. Concomitant production of immunoreactive gastrin-releasing peptide and calcitonin in medullary carcinoma of the thyroid.
Yamaguchi K; Abe K; Adachi I; Suzuki M; Kimura S; Kameya T; Yanaihara N
Metabolism; 1984 Aug; 33(8):724-7. PubMed ID: 6748945
[TBL] [Abstract][Full Text] [Related]
5. Elevation of serum pro-gastrin-releasing peptide in patients with medullary thyroid carcinoma and small cell lung carcinoma.
Ide A; Ashizawa K; Ishikawa N; Ishii R; Ando T; Abe Y; Sera N; Usa T; Tominaga T; Ejima E; Nakashima M; Ito K; Ito K; Eguchi K
Thyroid; 2001 Nov; 11(11):1055-61. PubMed ID: 11762716
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of calcitonin, somatostatin-like immunoreactivity, and carcinoembryonic antigen in two sisters suffering from familial thyroid medullary carcinoma.
Bethge N; Ahuja S; Diel F
Exp Clin Endocrinol; 1986 Dec; 88(3):365-72. PubMed ID: 2881797
[TBL] [Abstract][Full Text] [Related]
7. Plasma and tumor levels of somatostatin (SRIF) and somatostatin immunochemistry in medullary thyroid carcinoma: apparently discrepant preliminary results.
Franc B; Chayvialle JA; Modigliani E; Calmettes C; Caillou B; Dutrieux-Berger N; Houdent C; Kujas M
Henry Ford Hosp Med J; 1987; 35(2-3):147-8. PubMed ID: 2891647
[No Abstract] [Full Text] [Related]
8. [Immuno-histochemical study of medullary thyroid carcinoma].
Bessho T
Nihon Geka Gakkai Zasshi; 1987 Jul; 88(7):872-84. PubMed ID: 2890090
[TBL] [Abstract][Full Text] [Related]
9. Gastrin-releasing peptide-like immunoreactivity in medullary thyroid carcinoma.
Ghatei MA; Springall DR; Nicholl CG; Polak JM; Bloom SR
Am J Clin Pathol; 1985 Nov; 84(5):581-6. PubMed ID: 4061381
[TBL] [Abstract][Full Text] [Related]
10. Gastrin-releasing peptide-, calcitonin gene-related peptide-, and calcitonin-like immunoreactivity in human breast cyst fluid and gastrin-releasing peptide-like immunoreactivity in human breast carcinoma cell lines.
Weber CJ; O'Dorisio TM; McDonald TJ; Howe B; Koschitzky T; Merriam L
Surgery; 1989 Dec; 106(6):1134-9; discussion 1139-40. PubMed ID: 2588117
[TBL] [Abstract][Full Text] [Related]
11. Molecular forms of katacalcin, calcitonin gene-related peptide and gastrin-releasing peptide, in a human medullary thyroid carcinoma.
Conlon JM; McGregor GP; Wallin G; Grimelius L; Thim L
Cancer Res; 1988 May; 48(9):2412-6. PubMed ID: 3258543
[TBL] [Abstract][Full Text] [Related]
12. Production of immunoreactive corticotropin-releasing hormone in various neuroendocrine tumors.
Tsuchihashi T; Yamaguchi K; Abe K; Yanaihara N; Saito S
Jpn J Clin Oncol; 1992 Aug; 22(4):232-7. PubMed ID: 1359172
[TBL] [Abstract][Full Text] [Related]
13. Gastrin-releasing peptide gene expression in developing, hyperplastic, and neoplastic human thyroid C-cells.
Sunday ME; Wolfe HJ; Roos BA; Chin WW; Spindel ER
Endocrinology; 1988 Apr; 122(4):1551-8. PubMed ID: 3345727
[TBL] [Abstract][Full Text] [Related]
14. Production of gastrin releasing peptide by medullary carcinoma of the thyroid. An immunohistochemical study.
Kameya T; Bessho T; Tsumuraya M; Yamaguchi K; Abe K; Shimosato Y; Yanaihara N
Virchows Arch A Pathol Anat Histopathol; 1983; 401(1):99-107. PubMed ID: 6412451
[TBL] [Abstract][Full Text] [Related]
15. Gastrin Responses to a test meal in patients with familial medullary thyroid carcinoma.
O'Dorisio TM; Falko JM; Cataland S; Almoney RW; George JM; Mazzaferri EL; Reynolds JC
J Clin Endocrinol Metab; 1982 Apr; 54(4):798-802. PubMed ID: 7061688
[TBL] [Abstract][Full Text] [Related]
16. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.
Ekblom M; Välimäki M; Pelkonen R; Jansson R; Sivula A; Franssila K
Q J Med; 1987 Nov; 65(247):899-910. PubMed ID: 2901773
[TBL] [Abstract][Full Text] [Related]
17. Gastrin-releasing peptide immunoreactivity in medullary thyroid carcinoma.
Matsubayashi S; Yanaihara C; Ohkubo M; Fukata S; Hayashi Y; Tamai H; Nakagawa T; Miyauchi A; Kuma K; Abe K
Cancer; 1984 Jun; 53(11):2472-7. PubMed ID: 6370416
[TBL] [Abstract][Full Text] [Related]
18. Detection of gastrin-releasing peptide mRNA in small cell lung carcinomas and medullary thyroid carcinomas using synthetic oligodeoxyribonucleotide probes.
Suzuki M; Yamaguchi K; Abe K; Adachi N; Nagasaki K; Asanuma F; Adachi I; Kimura S; Terada M; Taya Y
Jpn J Clin Oncol; 1987 Jun; 17(2):157-63. PubMed ID: 3039200
[TBL] [Abstract][Full Text] [Related]
19. Determination of plasma calcitonin gene-related peptide concentrations by a new immunochemiluminometric assay in normal persons and patients with medullary thyroid carcinoma and other neuroendocrine tumors.
Carter WB; Taylor RL; Kao PC; Heath H
J Clin Endocrinol Metab; 1991 Feb; 72(2):327-35. PubMed ID: 1991803
[TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of continuous cell line MTC-SK derived from a human medullary thyroid carcinoma.
Pfragner R; Höfler H; Behmel A; Ingolic E; Walser V
Cancer Res; 1990 Jul; 50(13):4160-6. PubMed ID: 1972348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
